Vet-Sonotron® Therapy was developed over the past decade by the late award winning scientist and inventor Dr. Alfonso DiMino. Vet-Sonotron therapy, technically known as Pulsed Radio Frequency Therapy or PRFT works by means of a patented Corona Discharge Beam that is produced when a low radio frequency of 430 kHz, pulsed at a low sound frequency of 1 kHz is applied to a an electrode situated inside a hand-held Applicator. The Corona Discharge Beam is then directed to the problem area, directly above the skin of the patient providing a Treatment Unit (“TU”), which is a 15 second output followed by a 3 second shutdown. Dosage is controlled by the amount of TU’s applied, depending on the size and density of the area to be treated. Three different settings allow for treatment on any size animals from mice to elephants! The treatment protocol is normally 3 to 5 treatment visit with from 2 to 7 days between treatments. Chronic conditions may require several treatment visits. Results tend to be cumulative and after the last treatment, sustained pain reflief and increased range of motion has been recorded for extended periods approximating months.

Vet-Sonotron Therapy is one of the quickest, if not the quickest, safest and most effective, totally non-invasive alternative medical therapies for large and small animals for an almost immediate relief of pain due to osteoarthritis, joint inflammation, and performance injuries that affect muscles and that cause swelling in tissues. Vet-Sonotron almost immediately increases the speed and range of motion of an arthritic joint.  Pain relief can be achieved in as fast as 15 to 45 seconds. During therapy, the device does not touch the animal at all. The therapy is thus totally non-invasive and external, requiring no drugs, is comfortable, painless and has been proven safe for use. The device does not give any adverse side effects and removes the need for drugs.

In controlled clinical studies in humans the Sonotron yielded positive results in numerous indications the Sonotron yielded positive results in numerous indications: osteoarthritis, carpal tunnel syndrome, epicondylitis (tennis elbow), plantar fascitis, TMJ, bursitis, etc.

Animal studies have pointed to the mechanism of action being related to the reduction of collagen protein levels in the synovial fluid of Sonotron-treated joints versus untreated joints. Reduced collagen protein is consistent with reduced inflammation in a joint.

There has also been in-vitro analysis of densification of excised cartilage tissue as well as a reduction in free radicals in the treatment area. Additional physiological factors include improved revascularization and vasodilation in treated versus untreated areas.